Organon & Co. — Director's Dealing 2022

Jun 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2022-06-10

Reporting Person: LAZARUS ROCHELLE B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-10	Phantom Stock	$	A	5640	Acquired		Common Stock (5640)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	458	Direct
Common Stock	175	Indirect

Footnotes

F1: The number of shares of Organon & Co. ("Organon") common stock previously reported has been adjusted based on the finalization of certain calculations in connection with the separation of Organon from Merck & Co., Inc.

F2: Each phantom stock unit is an economic equivalent of one share of Organon common stock, or 1-for-1.

F3: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

F4: Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022.